Related Experiment Video
Updated: May 20, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Ouabain targets the unfolded protein response for selective killing of HepG2 cells during glucose deprivation
Tulay Ozdemir1, Rukiye Nar, Veli Kilinc
1Gazi State Hospital, Samsun, Turkey.
Abstract:
Ouabain is a cardiotonic steroid and specific inhibitor of the Na(+)/K(+)-ATPase. The relationship between ouabain treatment and the unfolded protein response (UPR) in cells is not precisely understood. Therefore, we studied the possible effects of ouabain on proliferation, apoptosis, and the UPR. HepG2 cells were cultured overnight and then treated with various concentrations of ouabain (0.75 to 750 nM) in the absence or presence of 10 mM 2-deoxyglucose (2-DG) for 48 hours. We also used real-time polymerase chain reaction to obtain quantitative measurements of expression levels of Grp78, Grp94, CHOP, MTJ-1, HKII, MDR-1, MRP-1, HO-1, and Par-4. Cell number, viability, and proliferation of HepG2 cells were monitored with a real-time cell analyzer system (xCELLigence). We show that ouabain modulates the UPR transcription program and induces cell death in glucose-deprived tumor cells. Ouabain at all concentrations showed no cytotoxicity whereas all concentrations were very effective under 2-DG stress conditions. Our findings show that disruption of the UPR during glucose deprivation could be an attractive approach for selective cancer cell killing and could provide a chemical basis for developing UPR-targeting drugs against solid tumors. Ouabain use as an adjunct to conventional cancer therapy also warrants vigorous investigation.
Insights
Ouabain disrupts the unfolded protein response (UPR) in glucose-deprived cancer cells, selectively inducing cell death. This suggests UPR disruption is a promising strategy for developing novel cancer therapies.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Ouabain is a cardiotonic steroid that inhibits the Na(+)/K(+)-ATPase.
- The precise relationship between ouabain and the unfolded protein response (UPR) remains unclear.
- Investigating ouabain's effects on cell proliferation, apoptosis, and UPR is crucial.
Purpose of the Study:
- To investigate the effects of ouabain on HepG2 cell proliferation, apoptosis, and UPR.
- To determine if ouabain modulates the UPR transcription program.
- To explore the potential of ouabain in cancer treatment, particularly under glucose-deprived conditions.
Main Methods:
- HepG2 cells were treated with varying concentrations of ouabain (0.75–750 nM) with or without 2-deoxyglucose (2-DG).
- Real-time PCR was used to quantify the expression of UPR-related genes (Grp78, Grp94, CHOP) and other relevant genes (MTJ-1, HKII, MDR-1, MRP-1, HO-1, Par-4).
- Cell number, viability, and proliferation were monitored using the xCELLigence real-time cell analyzer system.
Main Results:
- Ouabain treatment modulated the UPR transcription program in HepG2 cells.
- Ouabain induced cell death in glucose-deprived tumor cells.
- Ouabain exhibited no cytotoxicity at tested concentrations in normal conditions but was effective under 2-DG stress.
Conclusions:
- Disrupting the UPR during glucose deprivation offers a potential strategy for selective cancer cell killing.
- Ouabain's ability to modulate UPR provides a chemical basis for developing UPR-targeting drugs against solid tumors.
- Ouabain warrants further investigation as an adjunct therapy for conventional cancer treatment.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
10:43siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells
Published on: May 24, 2014
Related Concept Videos
The Unfolded Protein Response
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Regulation of the Unfolded Protein Response
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Cell Specific Gene Expression